Corps/e Fledgling Listing: This project is new and has been listed with us for less than six months. We list other projects with similar titles. Please check that you report any submissions under the correct listing. About Wires. Tissue. Nausea. Dark tunnels. Silicon. Doppelgangers. Insects under the skin. Nanobots. Transformation.Donna Haraway wrote that a cyborg does not recognise the Garden of Eden.A cyborg literature does not recognise the dichotomies of man and woman, human and machine, natural and artificial, self and other, inside and out.A mutant literature values change, merging, and transgression over wholeness or return.The Gothic digs down into soil. Cyberpunk peels back flesh. Corps/e wants to hear from writers who don’t flinch at what their work dredges up.Corps/e is a new magazine, created in the hope of finding new speculative stories that are radical, uncomfortable, monstrous, and alive. Artistic integrity, engagement in the power of prose, and a love of spec fic all matter more here than the rules of structure, genre, and grammar.If you believe in your talent but you struggle to find a home for your writing because of an experimental style, disturbing themes, graphic scenes, genre-hopping, being a downer, something people don’t get, try us. Submission Caps: They may close to submissions early if they reach their quota. Country of Publication & Year Established Ireland Established in 2026 Publication Medium & Frequency Electronic Publication Electronic PublicationUnknown publication frequency AI Policy Human-created work preferred, but limited AI use may be permitted in some circumstances (see their site for details) Fiction Open Audience:Open to a broad Audience.Genres: Fantasy Open to all/most Subgenres, including: Cross-Genre Horror Open to all/most Subgenres, including: Cross-Genre Science Fiction Open to all/most Subgenres, including: Cross-GenreLengths: Flash Fiction: Up to 1,000 words. Short Story: 1,000 - 7,500 words. Novelette: 7,500 - 10,000 words.Styles:Open to all/most Styles, including: Experimental, Mainstream.Topics: Open to all/most Topics.Payment:No monetary payment No monetary payment.Submissions:Method: Online form. Reprints: Reprints are NOT allowed.Simultaneous submissions: Simultaneous submissions are allowed.Media: Text. Always check guidelines for details and restrictions. If you aren't familiar with these terms, see our glossary. Go to publication's website Report: Submission/Response Correction/Update New Cover ArtSocial Platforms:None known For the Editor(s): Duosuma Submission Manager Link to Duotrope Corps/e Submission Statistics The statistics in this section are compiled from submission reports sent to us through our submission tracker. They are not provided by the publication's editors/staff or by Duotrope's admins. Information in this section is updated a few times per day. Learn more about the statistics. We have not received any submission reports for this listing in the past 12 months. Your Submissions This section is available to subscribers only. Join today! Before SubmittingWe cannot guarantee that the information on this page is correct. It is not unusual for publications to evolve or close without notice. We do our best to keep up, but it isn't always possible. Duotrope listings do not imply endorsement or recommendation of the project being listed. Before submitting, you should use your own judgment to determine whether the project meets your standards.Always read the full guidelines provided by the publisher.Try to read at least one previous publication to get a better idea of what the editor would like to see.Unless the publisher's guidelines state otherwise, always use industry standard manuscript formatting.Be professional, patient, and persistent. DatesLast Updated: 17 Sep 2026We check their guidelines for changes every four weeks, and we audit the listing twice a year. Cookie Consent: This site uses secure first-party cookies for essential, preference-setting, and statistical purposes. We do not use any marketing, advertising, or third-party cookies. Read our full cookie policy. Accept All Cookies Allow Essential Cookies Only